Dr. Brad Dickerson


Brad Dickerson, MD is Associate Professor of Neurology at Harvard Medical School and Director of the Front otemporal Disorders Unit at the Massachusetts General Hospital, an integrated multidisciplinary unit dedicated to the highest level of care of patients with these conditions. Dr. Dickerson is also on staff as a behavioral neurologist in the MGH Memory Disorders Unit.Dr. Dickerson is an active clinical consultant in many aspects of cognitive and behavioral neurology of neurodegenerative and related disorders, including frontotemporal dementia, primary progressive aphasia, Alzheimer's, mild cognitive impairment, posterior cortical atrophy, and related conditions, and the use of neuroimaging and other diagnostic markers in neurodegenerative diseases.

Dr. Sanford Auerbach


Dr. Auerbach is a member of the Alzheimer’s Association and has served as a member and recent chair of its Board of Directors. He was involved in administrative management of BU's Department of Neurology and had served as the interim chair of the Department. Dr. Auerbach is an Associate Professor of Neurology and Psychiatry. He is a board certified neurologist and a board certified sleep specialist.

Dr. Brent Forester


Brent P. Forester, MD, MSc, is the chief of the Center of Excellence in Geriatric Psychiatry at McLean Hospital and medical director for Behavioral Health and Evaluation and Research at Partners Population Health Management at Partners HealthCare. Dr. Forester is an expert in geriatric psychiatry, specializing in the treatment of older adults with depression, bipolar disorder, and behavioral complications of Alzheimer’s disease and related dementias. He is president-elect of the American Association for Geriatric Psychiatry (AAGP), a distinguished fellow of the American Psychiatric Association and has previously served on boards of the AAGP and the Alzheimer’s Association of Massachusetts/New Hampshire.

Dr. Kate Papp


Dr. Papp is a clinical neuropsychologist who sees patients with memory disorders and studies the earliest cognitive changes associated with Alzheimer’s disease. She is interested in improving our ability to capture the most subtle and early changes with the goal of secondary prevention.